Previous Article | Next Article ![]()
Journal of Virology, May 2000, p. 4902-4907, Vol. 74, No. 10
Centro de Investigation en Sanidad Animal,
INIA, Valdeolmos, 28130 Madrid,1
Departament de Química Orgànica, Universitat de
Barcelona, 08028 Barcelona,3 and Centro
de Biología Molecular "Severo Ochoa" (CSIC-UAM),
Cantoblanco, 28049 Madrid,5 Spain;
Institute of Virology and Immunoprophylaxis,
Mittelhäusern, Switzerland2; and
BBSRC Institute for Animal Health, Pirbright, Surrey GU24 ONF,
England4
Received 13 October 1999/Accepted 16 February 2000
T-cell epitopes within viral polypeptide VP4 of the capsid protein
of foot-and-mouth disease virus were analyzed using 15-mer peptides and
peripheral blood mononuclear cells (PBMC) from vaccinated outbred pigs.
An immunodominant region between VP4 residues 16 and 35 was identified,
with peptide residues 20 to 34 (VP4-0) and 21 to 35 (VP4-5)
particularly immunostimulatory for PBMC from all of the vaccinated
pigs. CD25 upregulation on peptide-stimulated CD4+
CD8+ cells
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Interspecies Major Histocompatibility Complex-Restricted Th Cell
Epitope on Foot-and-Mouth Disease Virus Capsid Protein VP4
dominated by Th memory cells in the pig
and
inhibition using anti-major histocompatibility complex class II
monoclonal antibodies indicated recognition by Th lymphocytes. VP4-0
immunogenicity was retained in a tandem peptide with the VP1 residue
137 to 156 sequential B-cell epitope. This B-cell site also retained
immunogenicity, but evidence is presented that specific antibody
induction in vitro required both this and the T-cell site. Heterotypic
recognition of the residue 20 to 35 region was also noted.
Consequently, the VP4 residue 20 to 35 region is a promiscuous,
immunodominant and heterotypic T-cell antigenic site for pigs that is
capable of providing help for a B-cell epitope when in tandem, thus
extending the possible immunogenic repertoire of peptide vaccines.
*
Corresponding author. Mailing address: Institute of
Virology and Immunoprophylaxis, Sensemattstrasse 293, 3147 Mittelhäusern, Switzerland. Phone: 41-31-8489361. Fax:
41-31-8489222. E-mail: kenneth.mccullough{at}ivi.admin.ch.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»